Skip to main content
Livermore
Livermore
ZHEN

Kura Oncology, Inc.

KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422143

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 3 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

Holders of 5% or more of KURA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kura Oncology, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of KURA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Biotechnology Value Fund L P13G/A9.99%8.68M shares+2.49 ppfrom 7.50%Feb 4, 20253 filingsNov 14, 2025SEC
Suvretta Capital Management, LLC13G/A9.40%7.56M shares+2.70 ppfrom 6.70%Feb 13, 20252 filingsMay 2, 2025SEC
BlackRock, Inc.13G/A7.80%6.33M shares−2.40 ppfrom 10.20%Jan 8, 20252 filingsApr 17, 2025SEC
Armistice Capital, LLC13G/A7.14%6.20M shares–Aug 15, 20251 filingAug 15, 2025SEC
State Street Corp13G5.70%4.93M sharesNewFeb 9, 20261 filingFeb 9, 2026SEC
Armistice Capital, LLC13G/A5.67%4.94M shares+0.30 ppfrom 5.37%Feb 14, 20254 filingsFeb 17, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

18 Schedule 13D and 13G filings on Kura Oncology, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on KURA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 27, 202610:21 AM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Feb 17, 20269:46 PM ETArmistice Capital, LLCand 1 other13G/A5.67%4.94M shares+0.30 ppfrom 5.37%Dec 31, 2025SEC
Feb 9, 20266:48 AM ETState Street Corp13G5.70%4.93M sharesNewDec 31, 2025SEC
Nov 14, 20256:45 PM ETArmistice Capital, LLCand 1 other13G/A5.37%4.67M shares−2.22 ppfrom 7.59%Sep 30, 2025SEC
Nov 14, 20254:12 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%8.68M shares+2.49 ppfrom 7.50%Sep 30, 2025SEC
Aug 15, 202512:26 PM ETArmistice Capital, LLCand 1 other13G/A7.14%6.20M shares–Jun 30, 2025SEC
Aug 14, 20251:26 PM ETEcoR1 Capital, LLCand 2 others13G/A4.80%4.20M shares–Below 5%Jun 30, 2025SEC
May 15, 20254:59 PM ETRa Capital Management, L.P.and 3 others13G/A4.90%4.00M shares–Below 5%Mar 31, 2025SEC
May 15, 20253:29 PM ETArmistice Capital, LLCand 1 other13G/A7.59%6.57M shares+0.13 ppfrom 7.46%Mar 31, 2025SEC
May 2, 20255:16 PM ETSuvretta Capital Management, LLCand 2 others13G/A9.40%7.56M shares+2.70 ppfrom 6.70%Mar 31, 2025SEC
Apr 17, 20259:35 AM ETBlackRock, Inc.13G/A7.80%6.33M shares−2.40 ppfrom 10.20%Mar 31, 2025SEC
Feb 14, 20255:30 PM ETArmistice Capital, LLCand 1 other13G7.46%5.80M sharesNewDec 31, 2024SEC
Feb 14, 20254:42 PM ETParadigm Biocapital Advisors LPand 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 13, 20258:15 PM ETSuvretta Capital Management, LLCand 2 others13G/A6.70%5.20M shares–Dec 31, 2024SEC
Feb 13, 20258:57 AM ETFlynn James Eand 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 4, 20258:09 PM ETBiotechnology Value Fund L Pand 9 others13G7.50%5.91M shares+3.20 ppfrom 4.30%Jan 27, 2025SEC
Feb 4, 20258:05 PM ETBiotechnology Value Fund L Pand 9 others13G/A4.30%3.41M shares–Below 5%Dec 31, 2024SEC
Jan 8, 20257:42 PM ETBlackRock, Inc.13G10.20%7.93M sharesNewDec 31, 2024SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Kura Oncology, Inc. shares, newest first.

Form 144 notices for KURA
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 24, 20264:05 PM ETFrancis J BurrowsOfficer20.7K$224.5KSep 24, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC